Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fenretinide × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

Specimen Handling 416 Magnetic Resonance Spectroscopy 337 pembrolizumab 311 Biopsy 233 Carboplatin 232 Cisplatin 195 Cyclophosphamide 182 Nivolumab 174 Gemcitabine 170 Paclitaxel 158 Bevacizumab 132 Radiotherapy 121 atezolizumab 103 Docetaxel 103 Dexamethasone 103 fludarabine 102 venetoclax 96 Oxaliplatin 93 Rituximab 89 durvalumab 88 Fluorouracil 87 Pemetrexed 85 Radiation 83 Doxorubicin 82 Prednisone 77 Ipilimumab 75 Taxes 73 Capecitabine 73 Leucovorin 70 Lenalidomide 70

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00646230 2026-04-14

IV Fenretinide

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡